Streetbeat News

Equity Actions

ICFI

IFC International has updated its FY23 guidance, expecting EPS of $6.40-$6.50 and revenue of $1.950B-$1.980B. The company's strong performance is attributed to growth markets such as utility consulting, disaster management, IT modernization/digital transformation, and climate, environment, and infrastructure services. The company also highlighted its recent recognitions, including being named one of America's Best Employers for Women by Forbes.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 8:45 pm

DIS

Activist investor Nelson Peltz of Trian Fund Management is targeting Disney (NYSE:DIS) with a growing stake in the company and pushing for changes. Peltz is seeking a position on the Board of Directors and has been backed by investor Ike Perlmutter, who has put his entire stake in Disney in Peltz's plan. The Trian stake in Disney is worth around $2.5 billion and would give Trian control of around 2% of outstanding shares. Disney shares are down 22% in the last year.

Portfolio Pulse from Chris Katje

November 02, 2023 | 8:15 pm

EXPE

Expedia Group has announced a $5 billion share repurchase authorization, indicating the company's confidence in its own stock and potentially leading to a rise in its share price.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 8:03 pm

BTCUSD

Fidelity's director of global macro, Jurrien Timmer, has reiterated his view of Bitcoin as a 'commodity currency', likening it to gold. He suggests that Bitcoin could outperform in the current economic climate of negative real interest rates and unchecked money supply expansion. This view adds to the growing discourse around Bitcoin's role in the global financial system, with the upcoming Benzinga's Future of Digital Assets conference expected to further this discussion.

Portfolio Pulse from Murtuza Merchant

November 02, 2023 | 7:02 pm

EEX

FLGC

GNLN

Several changes in leadership and board positions have occurred in the cannabis industry. Suzanne Bergeron has been appointed as the new president and CEO of the Société québécoise du cannabis (SQDC). In Morocco, Mohamed El Guerrouj has been named the general director of the Morocco National Agency for Regulating Cannabis Related Activities (ANRAC). In the U.S., Debra Hilton-Creek has been named the acting executive director of the Massachusetts Cannabis Control Commission (CCC). Several cannabis companies including Greenway Greenhouse Cannabis Corporation, StateHouse Holdings Inc., Glass House Brands Inc., Rubicon Organics Inc., Greenlane Holdings, Inc., Flora Growth Corp., and Nextleaf Solutions Ltd. have also announced changes in their board of directors.

Portfolio Pulse from Jelena Martinovic

November 02, 2023 | 6:41 pm

Goldman Sachs plans to promote 608 executives to managing directors, a decrease from the 643 promotions two years ago. This move reflects the firm's ongoing focus on advancing its strategic objectives and expanding its global footprint.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 6:36 pm

ABBV

BKH

FRT

KMB

KNGS

KVUE

LEG

MMM

SON

SWK

TGT

Roundhill Investments has launched the Roundhill S&P Dividend Monarchs ETF (NYSE:KNGS), the first-ever U.S. listed ETF to track the performance of Dividend Monarchs, a group of U.S. blue chip companies that have grown their dividends for 50+ consecutive years. The ETF includes 36 stock holdings, with top holdings including Leggett & Platt Inc (NYSE:LEG), 3M Co (NYSE:MMM), Federal Realty Investment Trust (NYSE:FRT), Black Hills Corp (NYSE:BKH), Stanley Black & Decker (NYSE:SWK), Sonoco Products (NYSE:SON), Target Corp (NYSE:TGT), Kimberly-Clark Corp (NYSE:KMB), AbbVie Inc (NYSE:ABBV), and Kenvue Inc (NYSE:KVUE).

Portfolio Pulse from Chris Katje

November 02, 2023 | 6:25 pm

CMPS

COMPASS Pathways plc (NASDAQ:CMPS) reported Q3 2023 financial results, showing a 67% increase in cash and cash equivalents to $248.0 million and a long-term debt of $28.4 million. The company's net loss and R&D expenses have also increased. COMPASS recently raised $125 million in gross proceeds from a private placement, which, along with a $50 million term loan facility and share sales, extends its runway to late 2025. The company's synthetic psilocybin therapeutic COMP360 is progressing in its Phase 3 clinical program for Treatment-Resistant Depression (TRD).

Portfolio Pulse from Lara Goldstein

November 02, 2023 | 6:16 pm

CSCO

A significant investor has taken a bearish stance on Cisco Systems (NASDAQ:CSCO), with 54% of recent trades being bearish and 45% bullish. The total amount for put options was $707,290 and for call options was $503,325. The targeted price range for Cisco Systems over the last 3 months has been $45.0 to $55.0. The current price of CSCO is up 0.93% at $52.67, with the next earnings expected in 13 days.

Portfolio Pulse from Benzinga Insights

November 02, 2023 | 6:03 pm

SNPX

Synaptogenix, Inc. (NASDAQ:SNPX) has partnered with Cannasoul Analytics Ltd. to support research and development of pharmaceutical therapeutics. Synaptogenix has obtained a preemptive right to fund further research and commercialization of certain intellectual property, technology, and future products developed by Cannasoul and licensed from The Technion. Cannasoul has developed technology in large disease markets including leukemia, epilepsy and sleep disorders.

Portfolio Pulse from Jelena Martinovic

November 02, 2023 | 5:21 pm